Low immunogenicity predicted for emerging avian-origin H7N9
暂无分享,去创建一个
A. D. De Groot | T. Ross | W. Martin | M. Ardito | Frances E Terry | L. Levitz | L. Moise
[1] Weizhong Yang,et al. Epidemiology of human infections with avian influenza A(H7N9) virus in China. , 2014, The New England journal of medicine.
[2] E. Riedmann. Human Vaccines & Immunotherapeutics , 2013, Human Vaccines & Immunotherapeutics.
[3] N. Cox,et al. Global concerns regarding novel influenza A (H7N9) virus infections. , 2013, The New England journal of medicine.
[4] Wenjun Song,et al. Human infections with the emerging avian influenza A H7N9 virus from wet market poultry: clinical analysis and characterisation of viral genome , 2013, The Lancet.
[5] D. Butler. Mapping the H7N9 avian flu outbreaks , 2013, Nature.
[6] S. Schmidt,et al. Fusion protein technologies for biopharmaceuticals : applications and challenges , 2013 .
[7] V. Jawa,et al. Immunogenicity of Therapeutic Fusion Proteins: Contributory Factors and Clinical Experience , 2013 .
[8] Robert B. Couch,et al. A Randomized Clinical Trial of an Inactivated Avian Influenza A (H7N7) Vaccine , 2012, PloS one.
[9] G. Air,et al. Evaluations for In Vitro Correlates of Immunogenicity of Inactivated Influenza A H5, H7 and H9 Vaccines in Humans , 2012, PloS one.
[10] S. Buus,et al. Conservation of HIV-1 T cell epitopes across time and clades: validation of immunogenic HLA-A2 epitopes selected for the GAIA HIV vaccine , 2012, Retrovirology.
[11] Rob J. De Boer,et al. Degenerate T-cell Recognition of Peptides on MHC Molecules Creates Large Holes in the T-cell Repertoire , 2012, PLoS Comput. Biol..
[12] R. Webster,et al. Impact of prior seasonal influenza vaccination and infection on pandemic A (H1N1) influenza virus replication in ferrets. , 2011, Vaccine.
[13] Anne S De Groot,et al. Coupling sensitive in vitro and in silico techniques to assess cross-reactive CD4(+) T cells against the swine-origin H1N1 influenza virus. , 2011, Vaccine.
[14] Libo Dong,et al. Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. , 2009, The New England journal of medicine.
[15] Leonard Moise,et al. Immunoinformatic comparison of T-cell epitopes contained in novel swine-origin influenza A (H1N1) virus with epitopes in 2008-2009 conventional influenza vaccine. , 2009, Vaccine.
[16] A. D. De Groot,et al. T cell epitope: Friend or Foe? Immunogenicity of biologics in context☆ , 2009, Advanced Drug Delivery Reviews.
[17] Anne S De Groot,et al. Reducing risk, improving outcomes: bioengineering less immunogenic protein therapeutics. , 2009, Clinical immunology.
[18] Volker Brauer,et al. Adjuvanted H5N1 vaccine induces early CD4+ T cell response that predicts long-term persistence of protective antibody levels , 2009, Proceedings of the National Academy of Sciences.
[19] Julie McMurry,et al. Prediction of immunogenicity: in silico paradigms, ex vivo and in vivo correlates. , 2008, Current opinion in pharmacology.
[20] T. Boone,et al. Clinical validation of the "in silico" prediction of immunogenicity of a human recombinant therapeutic protein. , 2007, Clinical immunology.
[21] A. D. De Groot,et al. Evolutionary deimmunization: an ancillary mechanism for self-tolerance? , 2006, Cellular Immunology.
[22] Anne S De Groot,et al. Engineering immunogenic consensus T helper epitopes for a cross-clade HIV vaccine. , 2004, Methods.
[23] Keiji Fukuda,et al. Influenza-associated hospitalizations in the United States. , 2004, JAMA.
[24] Keiji Fukuda,et al. Mortality associated with influenza and respiratory syncytial virus in the United States. , 2003, JAMA.
[25] Michael A. Gonzalez,et al. From genome to vaccine: in silico predictions, ex vivo verification. , 2001, Vaccine.
[26] M F del Guercio,et al. Several common HLA-DR types share largely overlapping peptide binding repertoires. , 1998, Journal of immunology.
[27] A. D. De Groot,et al. An interactive Web site providing major histocompatibility ligand predictions: application to HIV research. , 1997, AIDS research and human retroviruses.
[28] G. Neumann,et al. Rapid communications , 2012 .
[29] Tian Bai,et al. Preliminary Report: Epidemiology of the Avian Influenza A (H7N9) Outbreak in China , 2013 .
[30] J. Stockman. Cross-Reactive Antibody Responses to the 2009 Pandemic H1N1 Influenza Virus , 2011 .
[31] A. Pym. Terms of Use , 1999 .